The 1-year PFS rate was 75.2%, with a median PFS of 21.0 months, aligning with previous trials and highlighting olaparib's efficacy in maintaining remission in patients with HRD-positive ...

Personalized jewelry is a thoughtful gift that, if chosen well, will be cherished for decades. But with so many jewelry brands offering the same bland birthstone pendants and initial necklaces ...

Testing for BRCA mutations linked to breast and ovarian cancers could become easier and more accessible with the help of artificial intelligence, potentially allowing earlier treatment.